Institution

Bühler (United Kingdom)

GBcompany

Recent research

  • BiologyOpen access

    Before lowering blood pressure to prevent ARIA, we need evidence of net benefit

    Amyloid-related imaging abnormalities (ARIA) occur in 20-40% of patients treated with the amyloid-targeting drugs lecanemab and donanemab. While most cases of ARIA are asymptomatic, serious and fatal cases occur. Therefore, ARIA prevention remains vital as these drugs are increas...

    Zenodo (CERN European Organization for Nuclear Research)2026-09-260 citationsDOI
  • BiologyOpen access

    Before lowering blood pressure to prevent ARIA, we need evidence of net benefit

    Amyloid-related imaging abnormalities (ARIA) occur in 20-40% of patients treated with the amyloid-targeting drugs lecanemab and donanemab. While most cases of ARIA are asymptomatic, serious and fatal cases occur. Therefore, ARIA prevention remains vital as these drugs are increas...

    Zenodo (CERN European Organization for Nuclear Research)2026-09-260 citationsDOI
  • AI & ComputingOpen access

    A Cache Modeling Framework for Accelerator Systems

    Modern hardware accelerators increasingly rely on cache-based memory systems to improve modularity and tolerate irregular memory behavior in sparse and data-dependent workloads. However, configuring accelerator caches remains challenging: designers must choose cache capacity, Mis...

    ACM Transactions on Architecture and Code Optimization2026-08-220 citationsDOI